id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-1506-0012,FDA,FDA-2023-N-1506,Methodological Challenges Related to Patient Experience Data; Summary of Received Comments,Notice,General Notice,2023-12-13T05:00:00Z,2023,12,2023-12-13T05:00:00Z,,2023-12-13T16:28:58Z,2023-27312,0,0,0900006486331450
FDA-2023-N-1506-0011,FDA,FDA-2023-N-1506,Methodological Challenges Related to Patient Experience Data Summary of Received Comments,Other,Summary (SUM),2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,,2023-11-27T16:53:00Z,,0,0,090000648628ebe3
FDA-2023-N-1506-0001,FDA,FDA-2023-N-1506,Methodological Challenges Related to Patient Experience Data; Request for Information and Comments,Notice,Requests for Information (RFI),2023-05-02T04:00:00Z,2023,5,2023-05-02T04:00:00Z,2023-07-04T03:59:59Z,2023-08-15T01:03:14Z,2023-09265,0,0,09000064859b7b7d